title: CDw78--a determinant on a major histocompatibility complex class II subpopulation that can be induced to associate with the cytoskeleton.
abstract: In the present study we demonstrate that CDw78 monoclonal antibody (mAb) recognizes a distinct subpopulation of major histocompatibility complex (MHC) class II molecules. We show that the CDw78 epitope is present on less than 10% of the total number of MHC class II molecules expressed on different cells, is not linked to a single isotype, and exhibits a characteristic expression pattern in tonsils. While mAb against MHC class II (DR, DP and DQ) stained the majority of cells both in the mantle zone and in germinal centers, the CDw78 staining was more heterogeneous with the strongest reactivity and the highest number of positive cells in the mantle zone and in the light centrocyte-rich part of the germinal centers. Antibodies to this MHC class II subpopulation (e.g. FN1) induced association with the cytoskeleton and a subsequent capping in more than 90% of peripheral blood B cells. In contrast, mAb against MHC class II (DR, DP and DQ) did not induce association with the cytoskeleton and only 10-20% of B cells were induced to cap, suggesting that CDw78 defines a population of MHC class II molecules functionally different from the majority of these antigens. Scatchard plot analysis indicates that FN1 mAb is of relatively low affinity (Ka = 1.5 x 10(8) M(-1)) and monovalent Fab fragments fail to bind to the cell surface with measurable affinity. Our data seen in the context of the ability of FN1 to co-stimulate B cells with a suboptimal dose of anti-mu suggest that CDw78 mAb might recognize a functional important subpopulation of MHC class II molecules so far not described. It seems likely that this subpopulation represents dimerized or aggregated MHC class II molecules that can selectively bind this low-affinity mAb.
authors.affiliation: Department of Immunology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, Oslo. a.m.rasmussen@labmed.uio.no
authors.forename: A M
authors.initials: AM
authors.lastname: Rasmussen
authors.forename: V
authors.initials: V
authors.lastname: Horejsí
authors.forename: F O
authors.initials: FO
authors.lastname: Levy
authors.forename: H K
authors.initials: HK
authors.lastname: Blomhoff
authors.forename: E B
authors.initials: EB
authors.lastname: Smeland
authors.forename: K
authors.initials: K
authors.lastname: Beiske
authors.forename: T E
authors.initials: TE
authors.lastname: Michaelsen
authors.forename: G
authors.initials: G
authors.lastname: Gaudernack
authors.forename: S
authors.initials: S
authors.lastname: Funderud
mesh_terms: D000911:Antibodies, Monoclonal / Q000276:immunology; D015703:Antigens, CD / Q000276:immunology*; D001402:B-Lymphocytes / Q000276:immunology* / Q000648:ultrastructure; D002460:Cell Line; D003599:Cytoskeleton / Q000276:immunology*; D000939:Epitopes / Q000276:immunology; D000949:Histocompatibility Antigens Class II / Q000276:immunology*; D006801:Humans
chemical_list: D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D000939:Epitopes; D000949:Histocompatibility Antigens Class II